nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-0E9FDFF3·Framework v5.13·Pipeline v0.4·Evaluated 13 Nov 2026·OECD: 3.2 Clinical medicine·Subfield: Nutrition and Dietetics·Basis: Full text·Type: Observational cohort study

Hospital Regimens Including Probiotics Guide the Individual Development of the Gut Microbiome of Very Low Birth Weight Infants in the First Two Weeks of Life.

Kurath-Koller et al.Kurath-Koller, Neumann, Moissl-Eichinger et al.·2020·Nutrients·10.3390/nu12051256 ↗

Primary claim

We found that hospital regimens significantly influenced the microbiome composition, diversity and quantity right from the beginning and all the way up to the more mature microbiome starting from two to three weeks of age onwards.

Tentative · center, nutrition and regimen differences are inseparable in the three-center observational comparison
In brief

Longitudinal profiling maps early gut microbiome differences across three neonatal units, but center-level confounding prevents attribution to probiotic or antibiotic regimens.

ReliabilityCaveats4 of 4 checks completeRead the entry ↓
Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

BACKGROUND: It is unknown to what extent the microbiome of preterm infants is influenced by hospital regimens including the use of different probiotics when it comes to the prevention of necrotizing enterocolitis (NEC).

METHODS: Prospective controlled multicenter cohort study including very low birth weight infants from three neonatal intensive care units (NICUs) between October 2015 and March 2017. During this time span, stool was sampled every other day during the first two weeks and samples were subjected to amplicon-based microbiome analyses. Out of these, seventeen negative controls were processed (German Registry of Clinical Trials (No.: DRKS00009290)).

RESULTS: The groups (3 × 18 infants) showed no statistically significant difference regarding gestational age, birth weight, APGAR scores and oxygen demand. 2029 different taxa were detected, including Enterococcus and Staphylococcus, as well as the probiotic genera Lactobacillus and Bifidobacterium predominating. The bacterial load was found to increase earlier on when probiotics were used. Without probiotics administration, Lactobacillus and Bifidobacterium contributed only marginally to the fecal microbiome. Some infants did not respond to probiotic administration. The samples from all centers participating reached a very similar diversity after two weeks while the microbiome samples from all three centers clustered significantly yet varied from each other.

CONCLUSION: Probiotics proved to be safe and initiated an earlier increase of bacterial load (with marked individual divergences), which might play a crucial role in the prevention of neonatal morbidities. Meconium was found not to be free of bacterial DNA, and oral antibiotics did not influence the fecal microbiome development negatively, and hospital regimes led to a center-specific, distinct cluster formation.

Key Claims

Primary finding · Tentative

We found that hospital regimens significantly influenced the microbiome composition, diversity and quantity right from the beginning and all the way up to the more mature microbiome starting from two to three weeks of age onwards.

Fragile — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

center, nutrition and regimen differences are inseparable in the three-center observational comparison

Section 5, Conclusions
Quote verified
Secondary · Tentative

Probiotics were found to initiate an earlier increase of bacterial load, and this in turn might play a role in the prevention of neonatal morbidities.

confounded center comparisons cannot identify probiotic effects, and earlier load increase occurred only in Center G

Section 5, Conclusions
Quote verified
Secondary · Tentative

The use of an oral antibiotic for prophylaxis of NEC was found to not be associated with a reduced diversity or reduced abundance of microbiome signatures (disproval of hypothesis 2).

concurrent feeding and drug-regimen differences prevent the center comparison from excluding adverse antibiotic effects

Section 4, Discussion
Quote verified
Secondary · Tentative

Probiotics proved to be safe

the small survivor-only cohort and absence of systematically analyzed safety endpoints cannot establish safety

Abstract, Conclusion
Quote verified
Secondary · Supported

Notably, certain infants from centers G (5/18) and K (5/18) did not show any response to probiotic treatment, with restricted colonization by Lactobacillus, as compared to the other infants in the same study group (“high responders”).

individual longitudinal profiles document restricted Lactobacillus abundance within both probiotic centers

Section 3, Results
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#methodological rigour

Serial sampling captures early microbial development

Every-other-day stool sampling in 54 very low birth weight infants provides longitudinal observations spanning meconium and the first two weeks of life.

↳ Methods 2.1; Results

#contribution

Individual profiles reveal variable probiotic response

The Results identify restricted Lactobacillus abundance in 5 of 18 infants in each probiotic center, documenting heterogeneity obscured by center averages.

↳ Results, individual probiotic-response paragraph

#positioning

Discussion examines alternative microbial signal explanations

The Discussion considers primer bias in probiotic-genus abundance and possible environmental or formula-related sources of Geobacillus, connecting the observations to relevant literature.

↳ Discussion, primer-bias and Geobacillus paragraphs

Limitations

#methodological rigour

Center differences prevent treatment effect attribution

Probiotic, antibiotic, antifungal and feeding practices vary together across the three NICUs. The causal regimen conclusions and assertion of proven probiotic safety exceed what this comparison can establish.

↳ Methods 2.1; Abstract, Conclusion; Conclusions

#methodological rigour

General probiotic conclusion contradicts center findings

The Abstract and Conclusions attribute earlier bacterial-load increase to probiotics, but Results identifies the earlier increase only in Center G. The Discussion explicitly states that probiotic-only Center K did not show faster increases.

↳ Abstract, Results and Conclusion; Results, qPCR paragraph; Discussion, quantitative PCR paragraph

#methodological rigour

Longitudinal dependence and survivor selection remain unaddressed

Sample-wise comparisons use 383 observations from 54 infants without reported infant-level blocking or a repeated-measures model. Requiring three-week survival also restricts safety and NEC interpretations to survivors.

↳ Methods 2.1–2.2; Results, sample counts and diversity analyses

Does this match your read? Add your assessment ↓

Nabu Commentary

Serial stool sampling, 16S profiling and qPCR provide useful descriptive evidence of early microbiome development and individual variation across three NICUs. Because feeding and prophylaxis practices are nested within centers, the observed differences cannot establish separate probiotic or antibiotic effects. Sample-wise longitudinal testing and exclusion of early deaths further constrain inference. The general claim of probiotic-driven bacterial-load acceleration also conflicts with the Discussion's explicit account that the probiotic-only center showed no faster increase. Relevant literature discussion and a followable structure do not resolve these inferential and reporting limitations.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
2.5±0.1

Contribution
3.1

The study adds serial microbiome and bacterial-load observations in 54 very low birth weight infants across three NICUs, including individual variation in probiotic-genus abundance. Its advance remains descriptive because concurrent center practices cannot be separated.

Methods 2.1–2.2; Results
Methodological Rigour
1.9

Repeated sampling, qPCR and contamination filtering support descriptive measurements, but center-level confounding, sample-wise longitudinal inference and survivor selection substantially undermine regimen-specific conclusions. The general probiotic-load claim also conflicts with the center-specific account, as surfaced separately by the Red reliability flag.

Methods 2.1–2.2; Results, bacterial-load and diversity analyses; Discussion, quantitative PCR paragraph
Reporting
2.9

The hypotheses-to-results structure is followable, but incomplete statistical reporting and inconsistent summaries impede precise interpretation. These reporting limitations support a score below the band for a consistently supported, clearly communicated argument.

Introduction, hypotheses; Results, significance reporting; Abstract and Discussion
Positioning
2.9

The Discussion engages relevant work on microbial individuality, primer bias, Geobacillus and Klebsiella–NEC associations. Its limitations treatment does not adequately carry the combined center and feeding differences into the interpretation of regimen effects.

Discussion, primer-bias, Geobacillus and Klebsiella paragraphs; Limitations

Lower confidence on Reporting — domain match limited.

Reliability

Caveats4 of 4 checks


Results checkNoted
  • Probiotics were found to initiate an earlier increase of bacterial load: "The bacterial load was found to increase earlier on when probiotics were used." (Abstract (Results)) vs "the presence of probiotics in absence of antibiotics did not result in faster increases of bacterial load" (Discussion, paragraph on quantitative PCR data). Compare the general probiotic claim with the center-specific account: earlier increase occurred in Center G but not in the other probiotic center, K. → Not supported by the paper's own data
  • Meconium was not found to be free from bacterial DNA: "In total, 17 negative controls were processed and taken into account in subsequent analysis." (Methods 2.2 Microbiome analyses) vs "Overall, 383 samples and 16 negative controls, totaling more than 30 million reads, were processed for analysis." (Results, paragraph 2). Compare the Methods count of 17 negative controls included in analysis with the Results count of 16. → Effect on result unclear
Reporting and transparencyClean

Ethics approval, parental consent, trial registration and an ENA accession are declared. The historical NEC incidence dataset is explicitly attributed separately from the prospective cohort.

Ethics approval: declared · Data availability: declared

Reference IntegrityClean

36 of 37 checkable references verified

39 references in manuscript 2 are books, websites or datasets — counted, but not index-checkable

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 13 Nov 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Reproductive health and childbirth · Neonatal disorders
Type of advanceEmpirical
Route to useSuggested
AdvanceExtends
BeneficiariesLarge
CitationsFWCI 2.6
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessPiloted
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The claim rests on one small prospective cohort of 54 infants with amplicon sequencing, without independent confirmation or linked clinical outcomes.

From the paper
“Probiotics were found to initiate an earlier increase of bacterial load, and this in turn might play a role in the prevention of neonatal morbidities”

The paper links its probiotic findings to preventing neonatal morbidities but names no actor, profession or decision context.

Pathway

Neonatologists and NICU teams could use these findings to refine NEC prophylaxis regimens and probiotic selection, shaping early gut colonisation to prevent neonatal morbidities.

Barrier

Small single cohort, amplicon-based analyses, and no demonstrated link to NEC or other morbidities mean confirmatory trials are needed before regimens change.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Human Milk Oligosaccharides in Maternal Serum Respond to Oral Glucose Load and Are Associated with Insulin Sensitivity

    Weiser-Fuchs, Maggauer, van Poppel, et al. · 2023 · Health sciences

    Primary claim

    Serum 3'SL concentrations significantly increased from fasting to 1 h after glucose load, while concentrations of the other HMOs were unaltered.

    Tentative
    Evidence Score
    2.8±0.1
    Reliability
    Caveats
  2. Clinical NEC prevention practices drive different microbiome profiles and functional responses in the preterm intestine

    Neumann, Mahnert, Kumpitsch, et al. · 2023 · Clinical medicine

    Primary claim

    We demonstrate that preventive regimens have the highest impact on development and maturation of the gastrointestinal microbiome, enabling the establishment of a resilient microbial ecosystem that reduces pathogenic threats in at-risk preterm infants.

    Tentative
    Evidence Score
    2.7±0.1
    Reliability
    Caveats
  3. Maternal C-Peptide and Insulin Sensitivity, but Not BMI, Associate with Fatty Acids in the First Trimester of Pregnancy

    Bandres-Meriz, Majali-Martinez, Hoch, et al. · 2021 · Clinical medicine

    Primary claim

    Pregnant women (week 4+0–11+6) with a high C-peptide concentration and low insulin sensitivity (ISHOMA) had decreased serum concentration of total n-3 PUFA

    Supported
    Evidence Score
    3.2±0.2
    Reliability
    Caveats

How the rubric works →